目的探讨新生儿个体化发育支持和评估项目(newborn individualized development care and assessment program,NIDCAP)在早期早产儿全身运动(general movements,GMs)中的应用价值,旨在临床上对早产儿进行早期干预,改善神经发育预后。方法 2014年1-5月在本院新生儿科住院的早期早产儿为研究对象,分为干预组(n=41)和对照组(n=41)。对于干预组,入院即开始给予NIDCAP干预,对照组给予早产儿常规护理,评估两组早产儿在足月前的GMs。结果正常GMs NIDCAP干预组34例(82.9%),多于对照组[22例(53.6%)],而单调性扭动运动[5例(12.1%)]、痉挛-同步性扭动[2例(4.8%)]例数均少于对照组[分别为12例(29.2%)和7例(17.0%)],差异均有统计学意义(P<0.05)。结论通过NIDCAP干预可提高早期早产儿足月前正常GMs发生率,减少异常GMs发生率,可能会对神经发育结局有影响。 Objective To investigate the value of NIDCAP in the general movements (GMs) of early preterm infants, aimed at early intervention of premature infants clinically, Improve the prognosis of neurodevelopment. Methods From January to May 2014, patients with early premature infants hospitalized in neonates of our hospital were divided into intervention group (n = 41) and control group (n = 41). For the intervention group, NIDCAP intervention was started on admission, while the control group was given routine care for preterm infants, and the GMs of preterm infants in the two groups before term were evaluated. Results In the normal group, 34 cases (82.9%) were treated with NIDCAP, more than 22 cases (53.6%) in the control group, while monotonous writhing (5 cases, 12.1%), convulsion- (4.8%)] cases were fewer than those in the control group [12 (29.2%) and 7 (17.0%], respectively] with statistical significance (P <0.05). Conclusion NIDCAP intervention can increase the incidence of preterm preterm full term premature infant GMF and reduce the incidence of abnormal GMs, which may affect the outcome of neurodevelopment.